Telehealth services during the COVID-19 pandemic was perceived to be a good alternative to in-person healthcare appointments among people with…
Articles by Steve Bryson, PhD
The QIMR Berghofer Medical Research Institute has launched the Australian Parkinson’s Genetics Study (APGS), a large-scale research endeavor to…
A £500,000 ($650,000) investment by the National Health Service of England will expand a clinical trial in that country of the Personal…
Azilect (rasagiline) as an add-on therapy to Requip (ropinrole) improved sleep, reduced the need for sleep medications, and…
A new app called NMS Assist, designed to remotely monitor the non-motor symptoms of Parkinson’s disease, is being developed…
ABBV-951, a continuous infusion formulation of levodopa/carbidopa, brought comparable levels of levodopa into the bloodstream of healthy volunteers as surgically…
Anavex 2-73 (blarcamesine), an investigational oral therapy for Parkinson’s disease dementia, led to clinically meaningful improvements within all…
Offering more weekly exercise classes at a higher intensity over a wider geographical area may help to instill  better exercise habits…
A modified form of vitamin B3 called nicotinamide riboside (NR), taken as an oral supplement, increased levels of an energy…
Finger tapping data from Parkinson’s patients using smartphone screens were linked with disease severity in a large-scale analysis that…